Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Ocumension Therapeutics 

1477
Current price
5.08 HKD -0.19 HKD (-3.61%)
Last closed 5.29 HKD
ISIN KYG674111011
Sector Healthcare
Industry Biotechnology
Exchange Hong Kong Stock Exchange
Capitalization 4 264 848 277 HKD
Yield for 12 month -31.35 %
1Y
3Y
5Y
10Y
15Y
1477
21.11.2021 - 28.11.2021

Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. It discovers, develops, and commercializes therapies for ophthalmic patients. Its portfolio includes products and drugs for the treatment of chronic non-infectious uveitis, blepharitis, infective and allergic conjunctivitis, diabetic macular edema, dry eye, glaucoma and ocular hypertension, postoperative inflammation, choroidal neovascularization, bacterial conjunctivitis, retinitis pigmentosa, acute glaucoma, age-related macular degeneration, cornea graft rejection, myopia, and optic neuritis. It had various drug assets in its portfolio. The company was founded in 2017 and is headquartered in Suzhou, the People's Republic of China. Address: No. 1858 Yinzhongnan Road, Suzhou, China

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

77.22 HKD

P/E ratio

Dividend Yield

Current Year

+265 938 103 HKD

Last Year

+171 584 358 HKD

Current Quarter

+111 933 488 HKD

Last Quarter

Current Year

+155 833 185 HKD

Last Year

+111 091 527 HKD

Current Quarter

+67 691 610 HKD

Last Quarter

Key Figures 1477

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -285 640 195 HKD
Operating Margin TTM -95.87 %
PE Ratio
Return On Assets TTM -7.01 %
PEG Ratio
Return On Equity TTM -11.71 %
Wall Street Target Price 77.22 HKD
Revenue TTM 310 644 397 HKD
Book Value 4 HKD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 61.6 %
Dividend Yield
Gross Profit TTM 103 032 212 HKD
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin -104.01 %

Dividend Analytics 1477

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 1477

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 1477

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 9.9463
Price Sales TTM 13.729
Enterprise Value EBITDA -12.8969
Price Book MRQ 1.4607

Financials 1477

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 1477

For 52 weeks

4.13 HKD 7.76 HKD
50 Day MA 5.53 HKD
Shares Short Prior Month
200 Day MA 6.03 HKD
Short Ratio
Shares Short
Short Percent